ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1078

Cardiovascular Risk Awareness in Patients with Rheumatic Diseases: A Case-Control Study

Dionicio Angel Galarza-Delgado 1, Iris Colunga-Pedraza 2, Jose Azpiri-Lopez 2, Karla Paola Cuellar-Calderon2, Ileana Cecilia Reynosa-Silva 2, Marielva Castro-Gonzalez 2 and Carolina Marlene Martinez-Flores 2, 1Universidad Autonoma de Nuevo Leon "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico, 2Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Cardiovascular disease, Rheumatic disease, rheumatic education and prevention

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Epidemiology & Public Health Poster II: Spondyloarthritis & Connective Tissue Disease

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose:

Cardiovascular diseases are among the most common comorbidities in patients with rheumatic diseases (RD) and leads them to an overall increase of mortality in comparison to the general population. Risk reduction can be reached through different strategies that control traditional cardiovascular risk (CVR) factors. In order to start lifestyle changes it is necessary an adequate knowledge of the disease and its consequences. Furthermore, patients who perceive themselves at a higher risk of developing CVD are more likely to make changes. The precaution adoption process model (PAPM) is a self-applied questionnaire useful to evaluate the knowledge of cardiovascular risk and outlines the actions that have been taken by each patient. Therefore, the objective was to assess the awareness of their CVR in patients with/without rheumatic diseases.

Methods:

A cross-sectional, observational, single center study was designed. Patients were recruited at a community educational healthcare conference. Population was divided into two groups; case group, with the following RD: RA, SLE, SS, AS, Scleroderma, PsA and DM, and a control group with subjects without RD. After clinical history, subjects were asked if they considered themselves at a higher risk of having CVD and PAPM was used to stratify the stage assigned. Frequencies (%) and median values (q25-q75) were used for descriptive analysis and Chi Square test for comparisons.

Results: A total of 274 patients were included. Demographic characteristics are in table 1.
CVD risk perception as a binary variable was 56.1% and 47.8% in the case and the control groups, respectively (p= 0.167). Women and subjects with complete university education showed more awareness.
According to PAPM scale, most of the patients located themselves in stage 1 (27.1% vs 33.6% in case vs control groups; p= NS), which means they are unaware of their augmented CVR (Figure 1). In the subjects with RD, 66.5% have not made any changes to reduce their risk while 71.6 % of the controls neither. In the control and case group having hypertension makes them prone to start actions to reduce their CVR with an OR of 2.9 (95% CI 1.3-6.6, p=0.007) and OR 2.4 (95% CI 1.0-5.6, p=0.029), respectively. Only 31.4% of the case group received CVR advice from physician, as compared to 26.1% in control group (table 2).

Conclusion: Even though patients with RD have an increased CVR due to the inflammatory condition and coexistence of traditional CVR factors, most of the individuals perceived it the same as control group. Therefore, these could explain the lack of initiative to start actions to reduce their CVR. According to EULAR recommendations the rheumatologist is the one responsible and they should commit to give a better education.


Table 1 demographic characteristics

Table 1. Demographic Characteristics


p

Source of CVR information


table 3

Precaution Adoption Process Model -PAPM-


Disclosure: D. Galarza-Delgado, None; I. Colunga-Pedraza, None; J. Azpiri-Lopez, None; K. Cuellar-Calderon, None; I. Reynosa-Silva, None; M. Castro-Gonzalez, None; C. Martinez-Flores, None.

To cite this abstract in AMA style:

Galarza-Delgado D, Colunga-Pedraza I, Azpiri-Lopez J, Cuellar-Calderon K, Reynosa-Silva I, Castro-Gonzalez M, Martinez-Flores C. Cardiovascular Risk Awareness in Patients with Rheumatic Diseases: A Case-Control Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/cardiovascular-risk-awareness-in-patients-with-rheumatic-diseases-a-case-control-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-risk-awareness-in-patients-with-rheumatic-diseases-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology